HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Free Full Text (PDF) Free All Versions of this Article: 102/4/1677    most recent 01145.2006v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Tidball, J. G. Articles by Wehling-Henricks, M. Search for Related Content PubMed PubMed Citation Articles by Tidball, J. G. Articles by Wehling-Henricks, M.

INVITED REVIEW

HIGHLIGHTED TOPIC
Free Radical Biology in Skeletal Muscle

The role of free radicals in the pathophysiology of muscular dystrophy

Departments of ¹Physiological Science and ²Pathology and Laboratory Medicine, University of California, Los Angeles, California

Null mutation of any one of several members of the dystrophin protein complex can cause progressive, and possibly fatal, muscle wasting. Although these muscular dystrophies arise from mutation of a single gene that is expressed primarily in muscle, the resulting pathology is complex and multisystemic, which shows a broader disruption of homeostasis than would be predicted by deletion of a single-gene product. Before the identification of the deficient proteins that underlie muscular dystrophies, such as Duchenne muscular dystrophy (DMD), oxidative stress was proposed as a major cause of the disease. Now, current knowledge supports the likelihood that interactions between the primary genetic defect and disruptions in the normal production of free radicals contribute to the pathophysiology of muscular dystrophies. In this review, we focus on the pathophysiology that results from dystrophin deficiency in humans with DMD and the mdx mouse model of DMD. Current evidence indicates three general routes through which free radical production can be disrupted in dystrophin deficiency to contribute to the ensuing pathology. First, constitutive differences in free radical production can disrupt signaling processes in muscle and other tissues and thereby exacerbate pathology. Second, tissue responses to the presence of pathology can cause a shift in free radical production that can promote cellular injury and dysfunction. Finally, behavioral differences in the affected individual can cause further changes in the production and stoichiometry of free radicals and thereby contribute to disease. Unfortunately, the complexity of the free radical-mediated processes that are perturbed in complex pathologies such as DMD will make it difficult to develop therapeutic approaches founded on systemic administration of antioxidants. More mechanistic knowledge of the specific disruptions of free radicals that underlie major features of muscular dystrophy is needed to develop more targeted and successful therapeutic approaches.

nitric oxide; muscle disease

This article has been cited by other articles:

				C. Colussi, A. Gurtner, J. Rosati, B. Illi, G. Ragone, G. Piaggio, M. Moggio, C. Lamperti, G. D'Angelo, E. Clementi, et al. Nitric oxide deficiency determines global chromatin changes in Duchenne muscular dystrophy FASEB J, July 1, 2009; 23(7): 2131 - 2141. [Abstract] [Full Text] [PDF]

				T. F. Reardon and D. G. Allen Iron injections in mice increase skeletal muscle iron content, induce oxidative stress and reduce exercise performance Exp Physiol, June 1, 2009; 94(6): 720 - 730. [Abstract] [Full Text] [PDF]

				B. Blaauw, C. Mammucari, L. Toniolo, L. Agatea, R. Abraham, M. Sandri, C. Reggiani, and S. Schiaffino Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle Hum. Mol. Genet., December 1, 2008; 17(23): 3686 - 3696. [Abstract] [Full Text] [PDF]

				P. A. Grimsrud, H. Xie, T. J. Griffin, and D. A. Bernlohr Oxidative Stress and Covalent Modification of Protein with Bioactive Aldehydes J. Biol. Chem., August 8, 2008; 283(32): 21837 - 21841. [Abstract] [Full Text] [PDF]

				K. Hnia, J. Gayraud, G. Hugon, M. Ramonatxo, S. De La Porte, S. Matecki, and D. Mornet L-Arginine Decreases Inflammation and Modulates the Nuclear Factor-{kappa}B/Matrix Metalloproteinase Cascade in Mdx Muscle Fibers Am. J. Pathol., June 1, 2008; 172(6): 1509 - 1519. [Abstract] [Full Text] [PDF]

				N. P. Whitehead, C. Pham, O. L. Gervasio, and D. G. Allen N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice J. Physiol., April 1, 2008; 586(7): 2003 - 2014. [Abstract] [Full Text] [PDF]

				Y. Lecarpentier Physiological role of free radicals in skeletal muscles J Appl Physiol, December 1, 2007; 103(6): 1917 - 1918. [Full Text] [PDF]

				M. B. Reid Editorial J Appl Physiol, April 1, 2007; 102(4): 1299 - 1300. [Full Text] [PDF]